查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1750720

免疫组织化学市场规模、份额、趋势分析报告：按产品、应用、最终用途、地区和细分市场预测，2025 年至 2030 年

Immunohistochemistry Market Size, Share & Trends Analysis Report By Product (Antibodies, Equipment, Reagents, Kits), By Application (Diagnostics, Research), By End use (Hospitals & Diagnostic Laboratories), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

免疫组织化学市场的成长与趋势：

根据 Grand View Research, Inc. 的最新报告，全球免疫组织化学市场规模预计到 2030 年将达到 35 亿美元，预计 2025 年至 2030 年期间的复合年增长率为 6.93%。

对精准数据的高度需求推动了免疫组化（IHC）技术的多项进步，从而实现了精准且具有上下文相关性的数据分析。多重免疫组化、计算病理学和下一代免疫组化等先进技术的兴起正在推动全球市场的发展。免疫组化方案在临床病理学中越来越受欢迎，尤其是在肿瘤病理学、血液病理学和神经病理学等次专科领域。

这项技术在塑造癌症诊断领域中发挥着至关重要的作用。因此，癌症盛行率的上升预计将增加对免疫组化（IHC）的需求，从而促进市场成长。此外，IHC在药物研发活动中的广泛应用预计将在预测期内推动收益成长。全切片成像和数位影像分析可提供高度准确和客观的评估。因此，影像分析可用于药物研发的各个方面，例如药物重新定位、标靶检验、患者分层、生物标记表达研究、药物疗效和安全性研究等。

产业参与者意识到该领域带来的商机，正在持续采取策略性倡议，以提升其市场影响力。例如，2021年6月，PathAI与Astra Zeneca和第一三共株式会社合作，创建了一个基于机器学习的模型，可以自动量化乳癌样本中的HER2免疫组化影像。全球市场可望受益于已开发国家和新兴国家老年人口的成长。随着全球老年人口的增长，预计与老龄化相关的疾病的盛行率将急剧上升。

免疫组织化学市场亮点

  • 由于在疾病诊断和药物测试工作流程中进行的免疫组织化学检测中大量使用抗体，抗体产品领域在 2024 年占据了市场主导地位。
  • 由于 IHC 测试在诊断环境中的广泛应用，诊断应用领域在 2024 年引领了市场。
  • 由于製药公司对新药研发的投资不断增加，预计药物测试领域在预测期内将显着成长。
  • 医院和诊断实验室最终用途部分在 2024 年占据了最大的收益占有率。由于 IHC 在药物发现活动中的应用越来越多，研究机构在预测期内的复合年增长率预计将最快。
  • 由于癌症发病率高、主要参与者的存在以及医疗和生物技术领域的发展等多种因素，预计北美将在 2024 年成为最大的区域市场。
  • 预计亚太地区在预测期内将以最快的复合年增长率成长，其中中国市场成长最为迅速。中国监管核准的不断增加以及新型免疫组化 (IHC) 解决方案的推出，正在推动中国市场的成长。
  • 主要企业正在努力加强其市场地位并获得竞争优势。

目录

第一章调查方法与范围

第二章执行摘要

第三章免疫组织化学市场变数、趋势与范围

  • 市场介绍/电网展望
  • 市场规模和成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 免疫组织化学市场分析工具
    • 波特分析
    • PESTEL分析

第四章免疫组织化学市场：按产品的估计和趋势分析

  • 细分仪表板
  • 免疫组织化学市场：2024 年和 2030 年产品差异分析
  • 抗体
    • 一抗
    • 二抗
  • 装置
    • 玻片染色系统
    • 组织微阵列
    • 组织处理系统
    • 幻灯片扫描仪
    • 其他的
  • 试剂
    • 组织学染色
    • 封闭血清和试剂
    • 呈色受质
    • 固定试剂
    • 稳定剂
    • 有机溶剂
    • 蛋白水解酶
    • 冲淡
  • 套件

第五章免疫组织化学市场：应用评估与趋势分析

  • 细分仪表板
  • 免疫组织化学市场：2024 年和 2030 年应用趋势分析
  • 诊断
    • 癌症
    • 感染疾病
    • 心血管疾病
    • 自体免疫疾病
    • 糖尿病
    • 肾臟疾病
  • 调查

第六章免疫组织化学市场：依最终用途的估计和趋势分析

  • 细分仪表板
  • 免疫组织化学市场：最终用途变异分析，2024 年和 2030 年
  • 医院和诊断实验室
  • 研究机构
  • 其他的

第七章免疫组织化学市场：按地区估计和趋势分析

  • 2024 年及 2030 年免疫组织化学市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司分类
  • 公司热图分析
  • 公司简介
    • Thermo Fisher Scientific Inc.
    • F. Hoffmann-La Roche Ltd.
    • Merck KGaA
    • Danaher Corporation
    • PerkinElmer Inc.
    • Bio-Rad Laboratories, Inc.
    • Cell Signaling Technology, Inc.
    • Bio SB
    • Agilent Technologies, Inc.
    • Abcam Limited.
Product Code: GVR-1-68038-718-6

Immunohistochemistry Market Growth & Trends:

The global immunohistochemistry market size is estimated to reach USD 3.50 billion by 2030, registering to grow at a CAGR of 6.93% from 2025 to 2030 according to a new report by Grand View Research, Inc. The high demand for accurate data has driven several technological advancements in IHC techniques, resulting in the delivery of precise and contextual data analyses. The emergence of advanced techniques, such as multiplex IHC, computational pathology, and next-generation IHC, is driving the global market. Immunohistochemistry protocols have gained popularity in clinical pathology, especially in the subspecialties of oncologic pathology, hematopathology, and neuropathology.

The technique has played a vital role in shaping cancer diagnostics. Thus, the growing prevalence of cancer is expected to increase the demand for IHC, thus contributing to market growth. Furthermore, the wide application scope of IHC in drug discovery and development activities is expected to boost revenue growth over the forecast period. Whole slide imaging and digital image analysis offer highly accurate and objective evaluations. Thus, image analysis can be used across different aspects of drug discovery including drug repositioning, target validation, patient stratification, biomarker expression studies, and drug efficacy & safety studies.

Acknowledging the profitable opportunities posed by the space, operating players in the industry continue to undertake strategic initiatives to strengthen their market presence. For instance, in June 2021, PathAI, in collaboration with AstraZeneca and Daiichi Sankyo Company Ltd., created machine learning-based models to enable automated quantification of HER2 IHC images in breast cancer samples. The global market will benefit from the growing geriatric population in developed and developing nations. As the global geriatric population increases, the prevalence of age-related illnesses is predicted to rise drastically.

Immunohistochemistry Market Report Highlights:

  • The antibodies product segment led the market in 2024 owing to the high use of antibodies for immunohistochemistry assays carried out for disease diagnosis and drug testing workflows
  • The diagnostics application segment led the market in 2024 owing to the widespread application of IHC tests in diagnostic settings
  • The drug testing segment is expected to witness significant growth during the forecast period. This is due to increasing investment flow by pharmaceutical companies in R&D activities of novel drug discovery and development
  • The hospitals and diagnostic laboratories end-use segment accounted for the largest revenue share in 2024. Research institutes are expected to register the fastest CAGR over the forecast period owing to the increasing adoption of IHC in research institutes for drug discovery activities
  • North America emerged as the largest regional market in 2024 owing to the confluence of multiple factors, such as high cancer prevalence, presence of key players, and developed healthcare & biotechnological sectors
  • The Asia Pacific is projected to grow at the fastest CAGR over the forecast period with China being the fastest-growing market. Increasing regulatory approvals and the launch of novel IHC solutions in China are accelerating the country's market growth
  • Key players are engaged in making focused attempts to reinforce their market position and gain a competitive advantage

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Immunohistochemistry Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Immunohistochemistry Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Immunohistochemistry Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Immunohistochemistry Market: Product Movement Analysis, 2024 & 2030 (USD Million)
  • 4.3. Antibodies
    • 4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Primary Antibodies
      • 4.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Secondary Antibodies
      • 4.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Equipment
    • 4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Slide Staining System
      • 4.4.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Tissue Microarrays
      • 4.4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Tissue Processing Systems
      • 4.4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Slide Scanners
      • 4.4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.6. Others
      • 4.4.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Reagents
    • 4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Histological stains
      • 4.5.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Blocking Sera and Reagents
      • 4.5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Chromogenic Substrates
      • 4.5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.5. Fixation Reagents
      • 4.5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.6. Stabilizers
      • 4.5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.7. Organic Solvents
      • 4.5.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.8. Proteolytic Enzymes
      • 4.5.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.9. Diluents
      • 4.5.9.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Kits
    • 4.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Immunohistochemistry Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Immunohistochemistry Market: Application Movement Analysis, 2024 & 2030 (USD Million)
  • 5.3. Diagnostics
    • 5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. Cancer
      • 5.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Infectious Diseases
      • 5.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. Cardiovascular Diseases
      • 5.3.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.5. Autoimmune Diseases
      • 5.3.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.6. Diabetes Mellitus
      • 5.3.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.7. Nephrological Diseases
      • 5.3.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Research
    • 5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Immunohistochemistry Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Immunohistochemistry Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
  • 6.3. Hospitals & Diagnostic Laboratories
    • 6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Research Institutes
    • 6.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Immunohistochemistry Market: Regional Estimates & Trend Analysis

  • 7.1. Immunohistochemistry Market Share, By Region, 2024 & 2030 (USD Million)
  • 7.2. North America
    • 7.2.1. North America Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Norway Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Japan Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. China Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Australia Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. South Korea
      • 7.4.6.1. South Korea Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. South Africa Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. UAE Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Thermo Fisher Scientific Inc.
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. F. Hoffmann-La Roche Ltd.
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Merck KGaA
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Danaher Corporation
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. PerkinElmer Inc.
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Bio-Rad Laboratories, Inc.
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. Cell Signaling Technology, Inc.
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Bio SB
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Agilent Technologies, Inc.
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Abcam Limited.
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global Immunohistochemistry market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global Immunohistochemistry market, by End use, 2018 - 2030 (USD Million)
  • Table 6 North America Immunohistochemistry market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 8 North America Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 9 North America Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 11 U.S. Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 14 Canada Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 17 Mexico Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe Immunohistochemistry market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 21 Europe Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 23 UK Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 24 UK Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 25 UK Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Germany Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 27 Germany Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 28 Germany Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 30 France Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 31 France Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 33 Italy Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 36 Spain Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Denmark Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 39 Denmark Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 40 Denmark Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Sweden Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 42 Sweden Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 43 Sweden Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Norway Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 45 Norway Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 46 Norway Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Immunohistochemistry market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Japan Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 52 Japan Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 53 Japan Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 54 China Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 55 China Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 56 China Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 57 India Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 58 India Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 59 India Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Australia Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 61 Australia Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 62 Australia Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 63 South Korea Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 64 South Korea Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 65 South Korea Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Thailand Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 67 Thailand Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 68 Thailand Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America Immunohistochemistry market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 71 Latin America Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 72 Latin America Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Brazil Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 74 Brazil Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 77 Argentina Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 78 Argentina Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 79 MEA Immunohistochemistry market, by country, 2018 - 2030 (USD Million)
  • Table 80 MEA Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 81 MEA Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 82 MEA Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 83 South Africa Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 84 South Africa Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 85 South Africa Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 89 UAE Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 90 UAE Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 91 UAE Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Immunohistochemistry market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Immunohistochemistry market: Product outlook key takeaways
  • Fig. 20 Immunohistochemistry market: Product movement analysis
  • Fig. 21 Antibodies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Primary Antibodies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Secondary Antibodies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Equipment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Slide Staining System market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Tissue Microarrays market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Tissue Processing Systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Slide Scanners market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Histological stains market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Blocking Sera and Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Chromogenic Substrates market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Fixation Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Stabilizers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Organic Solvents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Proteolytic Enzymes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Diluents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Immunohistochemistry market: Application outlook key takeaways
  • Fig. 41 Immunohistochemistry market: Application movement analysis
  • Fig. 42 Infectious disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Infectious Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Cardiovascular Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Autoimmune Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Diabetes Mellitus market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Nephrological Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Research market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Immunohistochemistry market: End-use outlook key takeaways
  • Fig. 52 Immunohistochemistry market: End use movement analysis
  • Fig. 53 Hospitals & Diagnostic Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Research Institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Regional marketplace outlook, 2024 & 2030 (USD million)
  • Fig. 57 Regional marketplace: Key takeaways
  • Fig. 58 North America Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 U.S. Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Canada Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Mexico Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Europe Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 UK Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Germany Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 France Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Spain Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Italy Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Denmark Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Sweden Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Norway Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Asia Pacific Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Japan Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 China Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 India Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Australia Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 South Korea Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 Thailand Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Market participant categorization
  • Fig. 97 Immunohistochemistry market position analysis, 2024
  • Fig. 98 Strategic framework